CORCEPT THERAPEUTICS INC (CORT:NASDAQ)
$85.86 -21.64 (-20.1302%)
Analysed CORCEPT THERAPEUTICS INC (CORT:NASDAQ) News Sources
Why Healthcare Stocks Are Hot When the AI Trade Runs Cold
15-10-2026
yahoo.com
3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge
15-10-2026
yahoo.com
Buy 5 Top-Ranked Non-Tech Nasdaq Stocks to Maximize Q4 Gains
16-10-2026
yahoo.com
Can Lifyorli Aid Corcept's Long-Term Growth Prospects Beyond Korlym?
19-10-2026
yahoo.com
Genmab stock surges 9% following positive phase 3 ovarian cancer trial results
23-10-2026
yahoo.com
Corcept Therapeutics (CORT) Draws Options Attention, Is It Still 18% Below Fair Value?
15-10-2026
yahoo.com
Corcept Therapeutics (CORT) Stock Looks Fully Priced For Its Sales Story
15-10-2026
yahoo.com
The Zacks Analyst Blog Highlights Ross Stores, Roku, APA, Corcept Therapeutics and Halozyme Therapeutics
19-10-2026
yahoo.com
2026 ADA/EASD Consensus Report Recommends Screening for Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes
20-10-2026
yahoo.com
2 cash-producing stocks to research further and 1 we find risky
22-10-2026
yahoo.com
What is the current price of CORCEPT THERAPEUTICS INC (CORT:NASDAQ)?
The current price of CORCEPT THERAPEUTICS INC (CORT:NASDAQ) is $85.86.
CORCEPT THERAPEUTICS INC (CORT:NASDAQ) absolute price change since previous trading day?
The absolute price change of CORCEPT THERAPEUTICS INC (CORT:NASDAQ) since the previous trading day is $-21.64.
CORCEPT THERAPEUTICS INC (CORT:NASDAQ) percentage price change since previous trading day?
The percentage price change of CORCEPT THERAPEUTICS INC (CORT:NASDAQ) since the previous trading day is -20.1302%.
What is the most recent average sentiment score for CORCEPT THERAPEUTICS INC (CORT:NASDAQ)?
The most recent average sentiment score for CORCEPT THERAPEUTICS INC (CORT:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for CORCEPT THERAPEUTICS INC (CORT:NASDAQ)?
The most recent sentiment for CORCEPT THERAPEUTICS INC (CORT:NASDAQ) is .
SEC-8K** Filing Available For CORCEPT THERAPEUTICS INC (CORT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.